FDA Approves New Imaging Drug to Help Identify Ovarian Cancer LesionsThe U.S. Food and Drug Administration (FDA) has granted approval for Cytalux® (pafolacianine) for use in adults with ovarian cancer.1,2 Cytalux is an imaging drug developed to help surgeons better... By Editorial Team2 min readBookmark for laterReactions 0 reactions Comments0 comments
